IBO (Impact BioMedical, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by IBO officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-30 | Todd D Macko | Chief Financial Officer | Sell | — | — |
| 2026-03-25 | Jason Grady | Director | Sell | — | — |
| 2026-01-06 | DSS, INC. | 10%+ Owner | Sell | — | — |
| 2025-05-27 | DSS, INC. | 10%+ Owner | Sell | — | — |
| 2025-04-07 | Heng Fai Ambrose Chan | Director | Sell | — | — |
| 2025-04-07 | DSS, INC. | 10%+ Owner | Sell | — | — |
| 2025-04-04 | Alset Inc. | 10%+ Owner | Sell | — | — |
| 2025-04-02 | Heng Fai Ambrose Chan | Director | Sell | — | — |
| 2025-03-28 | DSS, INC. | 10%+ Owner | Sell | — | — |
| 2025-03-24 | DSS, INC. | 10%+ Owner | MIXED | — | — |
| 2024-12-09 | Frank D Heuszel | Chief Executive Officer | Buy | — | — |
| 2024-12-03 | Frank D Heuszel | Chief Executive Officer | Buy | — | — |
| 2024-12-03 | Frank D Heuszel | Chief Executive Officer | Buy | — | — |
| 2024-11-22 | DSS, INC. | 10%+ Owner | Sell | — | — |
| 2024-09-19 | DSS, INC. | 10%+ Owner | Buy | — | — |
| 2024-09-18 | DSS, INC. | 10%+ Owner | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 46,785 | — |
| — | 10%+ Owner | 28,043 | — |
| — | Director | 19,824 | — |
| — | Chief Financial Officer | 15,699 | — |
| — | Chief Executive Officer | 7,713 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the IBO quote page; the site-wide leaderboard is on the insider transactions hub.